Co-Pyronil 2

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

51 API Suppliers, 14 USDMF, 2 JDMF, 4 EU WC, 10 KDMF, 10 NDC API, 24 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

FINISHED DOSAGE FORMULATIONS

320 FDF Dossiers, 66 FDA Orange Book, 99 Europe, 37 Canada, 34 South Africa, 84 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;ORAL - 4MG/5ML;5MG/5ML, TABLET;ORAL - 2MG;200MG;30MG, TABLET;ORAL - 4MG;200MG;10MG, SOLUTION;ORAL - 4MG/5ML;5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 12MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 2 Evonik, 11 Rochem International Inc, 24 SPI Pharma, 2 Pharm-RX Chemical, 10 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 2 Kewpie Corporation, 16 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Capital Farma, 10 Kirsch Pharma, 2 Cerata Pharmaceuticals LLP, 20 Dr. Paul Lohmann GmbH & Co. KGaA, 4 ACG Worldwide, 14 Actylis, 3 Aeon Procare, 2 Alcedo Pharmachem, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 Ashland, 1 Avesta Pharma, 37 BASF, 1 Bioplus Life Sciences, 3 CD Formulation, 5 Clariant, 14 Corel Pharma Chem, 7 DFE Pharma, 1 Esteem Industries, 2 Finar, 14 Gangwal Chemicals, 1 Gloria Interchem, 9 Ideal Cures, 5 Ingredion Pharma Solutions, 2 JJ Chemicals, 26 Kerry, 4 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 22 Microlex e.U, 1 Nanjing Bold Chemical, 3 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 9 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 47 Roquette, 14 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 5 Silverline Chemicals, 1 Symrise, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 2 Valens Pharmachem, 5 Vasa Pharmachem, 1 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

103 Fillers, Diluents & Binders, 75 Coating Systems & Additives, 57 Thickeners and Stabilizers, 52 Solubilizers, 50 Direct Compression, 45 Disintegrants & Superdisintegrants, 45 Taste Masking, 39 Parenteral, 38 Controlled & Modified Release, 38 Granulation, 36 Topical, 32 Film Formers & Plasticizers, 30 Lubricants & Glidants, 24 Chewable & Orodispersible Aids, 23 API Stability Enhancers, 17 Co-Processed Excipients, 17 Emulsifying Agents, 9 Empty Capsules, 9 Rheology Modifiers, 7 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 19 News #PharmaBuzz

MARKET PLACE

36 APIs, 3 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 US Patents, 1 Health Canada Patents

REF. STANDARDS & IMPURITIES

8 JP, 1 Others

$ Xls

Filters

Co-Pyronil 2

Filters

FILTER :

filter Company Reset all filters

1 All

01 1Roquette

filter Capability Reset all filters

filter Country Reset all filters

01

Roquette

LYCAGEL

Health 2.0 Conference

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Looking for Co-Pyronil 2? Find Soft Gelatin used in Co-Pyronil 2 to address drug delivery challenges on PharmaCompass.

Co-Pyronil 2

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

51 API Suppliers

14 USDMF

2 JDMF

4 EU WC

10 KDMF

10 NDC API

24 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

5 Drugs in Development

FINISHED DOSAGE FORMULATIONS

320 FDF Dossiers

66 FDA Orange Book

99 Europe

37 Canada

34 South Africa

84 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;ORAL - 4MG/5ML;5MG/5ML

TABLET;ORAL - 2MG;200MG;30MG

TABLET;ORAL - 4MG;200MG;10MG

SOLUTION;ORAL - 4MG/5ML;5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 12MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Minakem

2 Evonik

11 Rochem International Inc

24 SPI Pharma

2 Pharm-RX Chemical

10 Boai NKY Pharmaceuticals Ltd

9 Gangwal Healthcare

2 Kewpie Corporation

16 Nanjing Well Pharmaceutical

2 Pfanstiehl

1 Capital Farma

10 Kirsch Pharma

2 Cerata Pharmaceuticals LLP

20 Dr. Paul Lohmann GmbH & Co. KGaA

4 ACG Worldwide

14 Actylis

3 Aeon Procare

2 Alcedo Pharmachem

11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

4 Ashland

1 Avesta Pharma

37 BASF

1 Bioplus Life Sciences

3 CD Formulation

5 Clariant

14 Corel Pharma Chem

7 DFE Pharma

1 Esteem Industries

2 Finar

14 Gangwal Chemicals

1 Gloria Interchem

9 Ideal Cures

5 Ingredion Pharma Solutions

2 JJ Chemicals

26 Kerry

4 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

22 Microlex e.U

1 Nanjing Bold Chemical

3 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

4 Novo Excipients

4 Pharmatrans-Sanaq

9 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

SOLUTION;ORAL - 4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 12MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 8MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons